Clinical trial

Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT

NCT03283566

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-10-03

PhasePHASE2

Study timeline

Study start (actual)2017-10-03Date precision: day

Registry last updated2022-04-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Pancreatitisunresolved

Insulin Dependent Diabetesunresolved

Interventions

HydroxychloroquineDRUG · verified · RxNorm: hydroxychloroquine

Sponsors & collaborators

The Cleveland Cliniclead sponsor

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)collaborator

Stanford Universitycollaborator

Mapped research locations

ClevelandOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03283566 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.